慢性阻塞性肺疾病合并肺癌发病机制的研究进展
作者:
作者单位:

(1. 山西医科大学第一临床医学院,太原 030001 ;2. 山西医科大学第一医院老年病科,太原 030001)

作者简介:

通讯作者:

中图分类号:

R563.9;R734.2

基金项目:


Research pregress of pathogenesis of chronic obstructive pulmonary disease complicated with lung cancer
Author:
Affiliation:

(1. First Clinical Medical College of Shanxi Medical University, Taiyuan 030001, China;2. Department of Geriatrics, First Hospital of Shanxi Medical University, Taiyuan 030001, China)

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    据统计,目前慢性阻塞性肺疾病(COPD)在全球40岁以上人群中发病率高达9%~10%。而世界卫生组织最新数据显示,肺癌发病率占全球新发癌症的11.6%,病死率达18.4%,是中国乃至全球发病率和病死率最高的癌症。COPD合并肺癌的年发病率为16.7%,且仍在上升。COPD合并肺癌治疗难度大,需在两种疾病基础上考虑治疗方案,病死率高,给医疗资源带来极大负担。COPD合并肺癌的发病机制复杂,且COPD本身就是肺癌发生的危险因素。本文对近年来COPD合并肺癌发病机制的研究进展进行综述。

    Abstract:

    According to statistics, the global incidence of chronic obstruction pulmonary disease (COPD) in the population aged over 40 years old is as high as 9%-10% at present. According to the latest data by Word Health Organization, lung cancer accounts for 11.6% of all new cancer cases in the world, with a case fatality rate of 18.4%. The lung cancer has the highest incidence rate and case fatality rate in China and even in the world. The annual incidence of COPD with lung cancer is 16.7% and is still rising. COPD with lung cancer is difficult to treat because a treatment plan should be considered both diseases. With a high fatality rate, the comorbidity poses a great burden on medical resources. The pathogenesis of COPD with lung cancer is complex, and COPD itself is a risk factor for lung cancer. In this paper, we reviewed the recent progress in the pathogenesis of COPD with lung cancer.

    参考文献
    相似文献
    引证文献
引用本文

张瑶,刘学军.慢性阻塞性肺疾病合并肺癌发病机制的研究进展[J].中华老年多器官疾病杂志,2022,21(1):76~80

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2020-12-03
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2022-01-29
  • 出版日期: